US · ITOC
iTonic Holdings Ltd.
- Sector
- Healthcare · Medical - Specialties
- Headquarters
- Beijing 100101
- Website
- ftzy.com.cn
Price · as of 2024-12-31
$0.35
Market cap 3.3M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $74.80 | +21,107.83% |
| Intrinsic Value(DCF) | $1.15 | +226.06% |
| Graham-Dodd Method(GD) | $0.23 | -35.64% |
| Graham Formula(GF) | $1.00 | +182.96% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | $0.00 | $0.03 | |||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $2.30 | $74.80 | $0.39 | $0.23 | $1.00 |
AI valuation
Our deep-learning model estimates iTonic Holdings Ltd.'s (ITOC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $74.80
- Current price
- $0.35
- AI upside
- +21,107.83%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.15
+226.06% upside
Graham-Dodd
$0.23
-35.64% upside
Graham Formula
$1.00
+182.96% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ITOC | iTonic Holdings Ltd. | $0.35 | 3.3M | +21,108% | +226% | -36% | +183% | -44.29 | 4.73 | 65.28 | -41.23 | -20.83 | 4.73 | 76.96% | -171.86% | -147.39% | -20.35% | -303.56% | -15.83% | 0.04 | — | 12.40 | 12.10 | 10.44 | 21265.00% | -2870.00% | 111914.00% | -2.65% | -1.44 | -305.76% | 0.00% | 0.00% | 19.96% | -30.31 | -30.09 | 52.09 | 33.27 |
About iTonic Holdings Ltd.
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
- CEO
- Jianfei Zhang
- Employees
- 10
- Beta
- 5.33
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.15 ÷ $0.35) − 1 = +226.06% (DCF, example).